MLYCD and pulmonary arterial hypertension: For example, abolished fatty acid oxidation by deleting the gene that encodes the regulating enzyme malonyl-coenzyme A decarboxylase (MCD) may shift the metabolic imbalance back to glucose oxidation; as a result, the mice did not develop pulmonary hypertension after MCT treatment or induced hypoxia condition [41].